Ten-years, single-center experience with Melody TPV implantation: early outcomes and mid-term follow-up
Anno:
2023
OBJECTIVES. Melody TPV is the first percutaneous valvular bio-prosthesis approved for trans-catheter pulmonary valve implantation (TPVI). We describe our ten-years experience about Melody TPV implantation in patients with congenital heart disease (CHD). METHODS. This is an observational retrospective single-center study. All patients undergone Melody TPV implantation were included. The early outcomes…